Andre Robidoux
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 29, 2023
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Journal: Breast cancer research and treatment
Published: May 04, 2022
Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec.
Journal: The oncologist
Published: January 14, 2022
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology).
Journal: Breast cancer research and treatment
Published: August 23, 2021
Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer.
Journal: Breast cancer research and treatment
Published: August 13, 2021
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.
Journal: JNCI cancer spectrum
Published: April 04, 2021
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
Journal: Breast cancer research : BCR
Published: January 24, 2020
NSABP B-41, a Randomized Neoadjuvant Trial: Genes and Signatures Associated with Pathologic Complete Response.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 16, 2020
NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 11, 2019
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer.
Journal: NPJ breast cancer
Published: October 08, 2019
Wage losses among spouses of women with nonmetastatic breast cancer.
Journal: Cancer
Published: August 28, 2019
Last Updated: 09/26/2026